Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-07-30 to 2024-08-20
Current total value of award: $46230.21
Description: 4565307573!XOLAIR 300 MG/2 ML AUTOINJECT 2ML